Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

An Open Label,Observational, Real Time Data Capturing of Usage & Outcome of Coseal

12. oktober 2012 opdateret af: Dr. Ali Zamir Khan, Medanta, The Medicity, India

An Open- Label,Multicentre, Observational, Prospective, Real-time Data Capturing of Usage, Outcome & Physician Satisfaction of Coseal in Cardio- Vascular- Thoracic Operative and Re- Operative Procedures

This study is Open- Label, Observational, Prospective, Real-time data capturing of Usage, Outcome & Physician satisfaction of Coseal in Cardio- Vascular-Thoracic Operative and Re- Operative procedures.

Objective of this study is to assess current practice pattern and best practice sharing of usage of Coseal by collecting data on (1) Sealing suture lines along arterial and venous reconstruction(2) Patients undergoing cardiac surgery to prevent or reduce the incidence, severity and extent of post surgical adhesion enforcement of suture lines in lung resection procedures (3) From this data to document and generate a real life experience on the use of Coseal in cardio vascular and thoracic surgery.

Number of expected patient enrollment is 750 from 20 participating sites.

Studieoversigt

Status

Ukendt

Betingelser

Detaljeret beskrivelse

Objectives:

  • Assessing current practice pattern and best practice sharing of usage of Coseal as per IFU by collecting data on oSealing suture lines along arterial and venous reconstructions oPatients undergoing cardiac surgery to prevent or reduce the incidence, severity and extent of post surgical adhesion enforcement of suture and staple lines in lung resection procedures
  • From this data to document and generate a real life experience on the use of Coseal in cardio vascular and thoracic surgery
  • To possibly create a guideline for usage of Sealant in routine practice in India
  • To study delivery methods and clinical impact in minimally invasive surgery like VATS and robotic surgery

End points

Primary Endpoint

  1. Cardio vascular sealing:

    To report the effectiveness and safety of COSEAL in the control of anastomotic suture line and needle hole suture bleeding during vascular reconstruction by checking the incidence of immediate anastomotic sealing and the presence of persistent intra-operative and postoperative bleeding average time to achieve hemostasis for a single bleeding site after 60 s of clamping without manual compression In case of sternotomy, Hemostasis time in mns, which is operative time comprised between the removal of cardio-pulmonary bypass cannulae and the closure of the sternum.

    Overall postoperative bleeding in mL/m² revision for bleeding Minor complications, major complications, mortality

  2. Efficacy of Coseal in prevention or reduction of adhesion in re-do surgeries for patients with staged operations for congenital cardiac malformation re-operated on during the follow-up period of the registry

    Incidence of adhesions. location and extension of adhesion by measuring the percentage of surface affected for each of the following regions: pericardial or retrosternal, inferior or diaphragmatic region, right lateral or atrial region, region around the great vessels, pulmonary surface.

    Overall evaluation (dissection easy or difficult) Incidence of subjects free of adhesions.

    Severity (at each of these sites, the adhesions will be graded as follows:

    absence of adhesion; 1: filmy and avascular; 2: dense and/or vascular; and 3: cohesive)

  3. Air leak: incidence of immediate (at the time of closure) and prolonged post-operative air leak, Use in redo surgery for air leak.

Secondary Endpoints

  1. Cardiovascular (sealing and adhesion prevention):

    1. Total operative time
    2. Nature and duration of first operation
    3. Nature and duration of redo operation, and time for dissection from sternotomy to end of dissection for prevention of adhesions )
    4. Length of intensive care stay
    5. Length of hospital stay
    6. Infection rate
    7. Quality of wound healing
    8. Quality of life (SF36)
  2. Thoracic and Lung

    1. Sealing the suture/ staple line on table Use of buttressing
    2. Total operative time
    3. Drain output
    4. Drain duration
    5. Length of hospital stay
    6. Prolonged air leak (more than 5 days) (>5 days is the new standard for prolonged aire leak accepted in 2011 by the EU Soc of CVTS, see ref.)
    7. Infection rate
  3. In all cases,

    1. intra and post-operative blood loss
    2. FFP, Transfusion
    3. Reoperation for bleeding purpose
  4. Others

    1. Surgeons satisfaction
    2. Easiness of product handling during application (VAS)

Undersøgelsestype

Observationel

Tilmelding (Forventet)

750

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Haryana
      • Gurgaon, Haryana, Indien, 122 001
        • Medanta, The Medicity

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 75 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

Patient falling under inclusion criteria can take part in to bthe study

Beskrivelse

Inclusion Criteria:

  1. Patients undergoing cardiovascular and thoracic surgery who require use of Coseal as a treatment strategy.
  2. Patient undergoing open, Video Assisted surgery and robotic surgery to be included and analysed as subgroups
  3. Written informed consent obtained from the patient or legal representative for data collection post surgery in patients who had Coseal used intraoperatively (data privacy laws).

Exclusion Criteria:

  1. Known hypersensitivity to components of the investigational product
  2. Known Immune system disorders, immunodeficiency
  3. Concomitant use of any other anti-adhesion product
  4. Concurrently participating in another clinical trial and having received another investigational drug or device within the last 30 days
  5. Unplanned re-operation in case of use for anti-adhesion
  6. Contraindications for use of Coseal

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Cardio Vascular Outcome
Tidsramme: 18 months
To report the effectiveness and safety of COSEAL in the control of anastomotic suture line and needle hole suture bleeding during vascular reconstruction by checking the incidence of immediate anastomotic sealing and the presence of persistent intra-operative and postoperative bleeding
18 months

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Cardiovascular (sealing and adhesion prevention):
Tidsramme: 18 months
To Capture total operative time,nature and duration of first operation,nature and duration of redo operation, and time for dissection from sternotomy to end of dissection for prevention of adhesions )
18 months
Thoracic and Lung (Sealing and Adhesion prevention)
Tidsramme: 18 months
18 months

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Dr. Ali Z Khan, MS,FRCS,FRCS, Medanta, The Medicity

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. december 2012

Primær færdiggørelse (Forventet)

1. november 2013

Studieafslutning (Forventet)

1. maj 2014

Datoer for studieregistrering

Først indsendt

8. oktober 2012

Først indsendt, der opfyldte QC-kriterier

12. oktober 2012

Først opslået (Skøn)

15. oktober 2012

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

15. oktober 2012

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

12. oktober 2012

Sidst verificeret

1. oktober 2012

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • MM/CTVS/2012/001

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Kirurgi

Abonner